Rituximab in Chronic Lymphocytic LeukemiaJAGLOWSKI, Samantha M; BYRD, John C.Seminars in hematology. 2010, Vol 47, Num 2, pp 156-169, issn 0037-1963, 14 p.Article

The clinical application of monoclonal antibodies in chronic lymphocytic leukemiaJAGLOWSKI, Samantha M; ALINARI, Lapo; LAPALOMBELLA, Rosa et al.Blood. 2010, Vol 116, Num 19, pp 3705-3714, issn 0006-4971, 10 p.Article

Lymphoma in Adolescents and Young Adults : IMPACT OF MALIGNANT DISEASE ON YOUNG ADULTS IIJAGLOWSKI, Samantha M; LINDEN, Erica; TERMUHLEN, Amanda M et al.Seminars in oncology. 2009, Vol 36, Num 5, pp 381-418, issn 0093-7754, 38 p.Article

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765HERMAN, Sarah E. M; GORDON, Amber L; HAMDY, Ahmed et al.Blood. 2011, Vol 117, Num 23, pp 6287-6296, issn 0006-4971, 10 p.Article

Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemiaJAGLOWSKI, Samantha M; RUPPERT, Amy S; ANDRITSOS, Leslie A et al.British journal of haematology. 2012, Vol 159, Num 1, pp 82-87, issn 0007-1048, 6 p.Article

Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor IbrutinibWOYACH, Jennifer A; FURMAN, Richard R; DAVE, Sandeep S et al.The New England journal of medicine. 2014, Vol 370, Num 24, pp 2286-2294, issn 0028-4793, 9 p.Article